Medicare IVIG Access Act of 2007

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 S. 3408, Comparative Effectiveness Research Act of 2008 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $620,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR. 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S. 2990 Medicare IVIG Access Act HR. 1282: Medigap Access Improvement Act ( Medigap insurance expansion)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologics; all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates, Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR. 2914: Medicare IVIG Access Act / HR. 2770: Medicare Part B Prompt-Pay exclusion from Average Sales Price Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S. 2990: Medicare IVIG Access Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Competitive Acquuisition Program for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2008; all aspects

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Comparative Effectiveness, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Carve-out of Generic Drugs from State Generic Substituion Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357- Protecting Records, Optimizing Treatment and Easing Communcations through Healthcare Technology PRO(TECH)T Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Afforadable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S. 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S. 2990 - Medicare IVIG Acces Act of 2007; all aspects HR. 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357 - Protecting Records, Optimimizing Treatment and Easing Communications through Healthcare Technology (PRO[TECH]HIT) Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personlized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S 1814 - Health Information Privacy and Security Act; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Medicare Demonstration Projects for Durable Medical Equipment HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicaer IVIG Access Act of 2008; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2914 Medicare IVIG Access Act of 2007, to assure Medicare coverage for patients who use intravenous immune globulin; H.R. 1282 Medigap Access Improvement Act of 2007, to make mandatory Medigap coverage for all states, various bills addressing the issue of follow-on biologics; FDA safety legislation pharmaceutical pedigree legislation; comparative effectiveness legislation

Client expense: $25,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE

General issues regarding Medicare and Medicaid; HR 2914, S 2990, regarding intravenous immunoglobulin (IVIG); HR 6331 and S 3101, regarding Medicare improvements for patients and providers; S 558, HR 1424, Mental Health Parity, as it relates to Medicaid rebate

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare IVIG Access Act, HR 2914 and S. 2990.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1245/S. 432, Kidney Disease Educational Benefits Act of 2007 regarding Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education H.R. 1193/S. 691, The Kidney Care Quality and Improvement Act of 2007 regarding all issues related to Medicare coverage of pre-ESRD education H.R. 2914/S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 6331/S. 3101, Medicare Improvements for Patients and Providers Act, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 3118, Preserving Access to Medicare Act of 2008, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 558, Mental Health Parity Act of 2007, as it relates to Medicaid rebates H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, as it relates to Medicaid rebates Drug and biological product pricing and reimbursement Durable Medical Equipment (DME) payment Product Payment Issues Therapy Payment Issues

Client expense: $720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 S. 3408, Comparative Effectiveness Research Act of 2008 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $720,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR. 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S. 2990 Medicare IVIG Access Act HR. 1282: Medigap Access Improvement Act ( Medigap insurance expansion) HR. 6331: Medicare Improvement For Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR. 2914: Medicare IVIG Access Act/ HR. 2770: Medicare Part B Prompt-Pay exclusion from Average Sales Price Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S. 2990: Medicare IVIG Access Act HR. 6331: Medicare Improvement for Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid pharmacy reimbursement; Medicare reimbursement for IVIG, including provisions in H.R. 2914 and S. 2990 The Medicare IVIG Access Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.

Client expense: $320,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services; H.R. 6331 / S. 3101, Medicare Improvements for Patients and Providers Act, as it pertains to pre-dialysis education for certain M-care beneficiaries; S. 3118, Preserving Access to Medicare Act, as it pertains to pre-dialysis education for certain M-care beneficiaries: S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates, Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Inappropriate use of Human Growth Hormone, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Carve-out of Generic Drugs from State Generic Substitution Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $434,097 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects HR 6898 - Health e-Information Technology Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE

General issues regarding Medicare and Medicaid; Hr 2914, S 2990, regarding intravenous immunoglobulin (IVIG); HR 6331 and S 3101, regarding Medicare improvements for patients and providers; S 558, HR 1424, Mental Health Parity, as it relates to Medicaid rebate

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services; H.R. 6331 / S. 3101, Medicare Improvements for Patients and Providers Act, as it pertains to pre-dialysis education for certain M-care beneficiaries; S. 3118, Preserving Access to Medicare Act, as it pertains to pre-dialysis education for certain M-care beneficiaries: S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1245/S. 432, Kidney Disease Educational Benefits Act of 2007 regarding Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education H.R. 1193/S. 691, The Kidney Care Quality and Improvement Act of 2007 regarding all issues related to Medicare coverage of pre-ESRD education H.R. 2914/S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 6331/S. 3101, Medicare Improvements for Patients and Providers Act, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 3118, Preserving Access to Medicare Act of 2008, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 558, Mental Health Parity Act of 2007, as it relates to Medicaid rebates H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, as it relates to Medicaid rebates Drug and biological product pricing and reimbursement Durable Medical Equipment (DME) payment Product Payment Issues Therapy Payment Issues

Client expense: $900,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $900,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S 2990 Medicare IVIG Access Act HR 1282: Medigap Access Improvement Act (Medigap insurance expansion) HR 6331 :Medicare Improvement For Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid pharmacy reimbursement; Medicare reimbursement for IVIG, including provisions in H.R. 2914 and S. 2990 The Medicare IVIG Access Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2914: Medicare IVIG Access Act Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S 2990: Medicare IVIG Access Act HR 6331: Medicare Improvement for Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c) S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

Medicare Part D, Prompt Payment of Pharmacy Claims, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Tracking the Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Preserving Access to Medicare Act of 2008; sections 132, 145, 161-167

Client expense: $508,492 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE

H.R. 2914 the "Medicare IVIG Access Act of 2007" regarding improved access to immune globulins. Sec 4 regarding coverage of home administration of IVIG; Pharmacy enhancements for consideration to the Medicare Modernization Act - no specific legislation this reporting period; H.R. 6331 the "Medicare Improvements for Patients and Providers Act of 2008" - Sec. 154 regarding a delay in the competitive acquisition program for DME

Client expense: $310,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 2914 Medicare IVIG Access Act of 2007, to assure Medicare coverage for patients who use intravenous immune globulin; H.R. 1282 Medigap Access Improvement Act of 2007, to make mandatory Medigap coverage for all states, various bills addressing the issue of follow-on biologics, pharmaceutical pedigree legislation

Client expense: $15,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 - Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 6252 and S 3144 - Medicare DMEPOS Competitive Acquisition Reform Act of 2008; all aspects HR 6331 - Medicare Improvement for Patients and Providers Act of 2008; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects S 3101 - Medicare Improvements for Patients and Providers Act of 2008; all aspects S 3118 - Craig Thomas Rural Hospital and Provider Equity Act of 2008; sections 132, 145, 161-167

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 5683 - Government Accountability Office Act of 2008, section 721 HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects S 2161 - Community Pharmacy Fairness Act of 2007; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 2914 Medicare IVIG Access Act of 2007, to assure Medicare coverage for patients who use intravenous immune globulin; H.R. 1282 Medigap Access Improvement Act of 2007, to make mandatory Medigap coverage for all states, various bills addressing the issue of follow-on biologics, pharmaceutical pedigree legislation

Client expense: $25,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Medicare Part D, Prompt Payment to Pharmacies, Antitrust Exemption for Pharmacists, IVIG Payments, Tracking or Pedigree of Prescription Drugs, Reimportation of Prescription Drugs, Medicare Demonstration Project for Durable Medical Equipment HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 3700 Fair Medicaid Drug Payment Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 Pharmaceutical Market Access Act of 2007; all aspects S 273 Prescription Drug and Health Improvement Act of 2007; all aspects S 1507 Access to Medicare Data Act of 2007; all aspects S 2219 Medicare Prescription Drug Savings and Choice Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

Health information technology, Electronic prescribing, Genetic Nondiscrimination, Inappropriate Use of Human Growth Hormone, Contract Disclosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-label Use of Prescription Drugs HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects HR 2914 - Medicare IVIG Access Act of 2007; all aspects HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects H.R. 5629 - Pathway for Biosimilars Act; all aspects S 28 - Generics First Act of 2007; all aspects S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects S 251 - Pharmaceutical Market Access Act of 2007; all aspects S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1507 - Access to Medicare Data Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects

Client expense: Not reported · Firm income: $60,000

Medicaid pharmacy reimbursement; Medicare reimbursement for IVIG, including provisions in H.R. 2914 the Medicae IVIG Access Act

Client expense: Not reported · Firm income: $50,000

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 3162, the Childrens Health and Medicare Protection Act (CHAMP) and the Medicare, Medicaid and SCHIP Extension Act of 2007 (S. 2499) as it relates to Medicaid Rebate issues and Kidney Disease Education. The Childrens Health Insurance Program Reauthorization Act of 2007 (H.R. 976) as it relates to Medicaid Rebate issues; Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1663: Medicare Mental Health Modernization Act S 1103: Helping Fill the Medicare Rx Gap Act S 1108: Medicare Part D Outreach and Enrollment Enhancement Act S 1701: TMA/Medicare Advantage S 1883 Accountability and Transparency in Medicare Marketing Act of 2007 S 2499 Medicare, Medicaid & SCHIP Extension Act of 2007. S 1218 Medicare for All Act HR 2034 Medicare for All Act S 130 Medicare Cost Contract Extension & Retirement Act of 2007 S3 Medicare Prescription Drug Price Negotiation Act of 2007 HR 4 Medicare Prescription Drug Price Negotiation Act of 2007 HR 976 Children's Health Insurance Program Reauthorization Act of 2007 HR 971 Community Pharmacy Fairness Act of 2007 Medicare; Medicare Advantage; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Helath Records; Pay for Performance S. 2785: Save Medicare Act of 2008 H.R. 4296/S. 2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act H.R. 5613: Protecting the Medicaid Safety Net Act of 2008; Comparative Effectiveness; Medicare Reform HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007 HR 2606 340B Program Improvement and Integrity Act of 2007 HR 2914 Medicare IVIG Access Act of 2007 HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007 S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007 S 1376 340B Program Improvement and Integrity Act of 2007 S 1507 Access to Medicare Data Act of 2007 S 1544 Medicare Quality Enhancement Act of 2007 Competitive Bidding Contract Disclosure Regulations 340B Program H.R. 2945 Medicare Advantage Truth in Advertising Act H.Con Res. 312 Budget Resolution S. 1954 Pharmacy Access Improvement Act S. 2408 Medicare Electronic Medication and Safety Protection Act H.Con Res. 70 Budget Resolution S 1893/HR 976 Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162: Children's Health and Medicare Protection Act of 2007 S. 2499 Medicare, Medicaid & SCHIP Extension Act of 2007.

Client expense: Not reported · Firm income: $75,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE